DMW – Klinischer Fortschritt, Table of Contents Dtsch Med Wochenschr 2012; 137(49): 2537-2539DOI: 10.1055/s-0032-1327282 Angiologie | Commentary Angiologie, Hämostaseologie © Georg Thieme Verlag KG Stuttgart · New York Schulter-Armvenenthrombose Upper extremity deep venous thrombosis M. Czihal 1 Sektion Angiologie-Gefäßzentrum, Medizinische Klinik und Poliklinik IV, Klinikum der LMU München , A. Schroettle 1 Sektion Angiologie-Gefäßzentrum, Medizinische Klinik und Poliklinik IV, Klinikum der LMU München , U. Hoffmann 1 Sektion Angiologie-Gefäßzentrum, Medizinische Klinik und Poliklinik IV, Klinikum der LMU München › Author Affiliations Recommend Article Abstract Buy Article Schlüsselwörter SchlüsselwörterSchulter-Armvenenthrombose - Thromboseprophylaxe Keywords Keywordsupper extremity deep venous thrombosis - prevention Full Text References Literatur 1 Bates SM, Jaeschke R, Stevens SM et al. Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (Suppl. 02) e351S-418S 2 Constans J, Salmi LR, Sevestre-Pietri MA et al. A clinical prediction score for upper extremity deep venous thrombosis. Thromb Haemost 2008; 99 (01) 202-7 3 Czihal M, Paul S, Rademacher A et al. Impact of the postthrombotic syndrome on quality of life after primary upper extremity deep venous thrombosis. Vasa 2012; 41: 200-204 4 Di Nisio M, Van Sluis GL, Bossuyt PM et al. Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review. J Thromb Haemost 2010; 8: 684-692 5 Flinterman LE, van Hylckama Vlieg A et al. Recurrent thrombosis and survival after a first venous thrombosis of the upper extremity. Circulation 2008; 118: 1366-1372 6 Gharagozloo F, Meyer M, Tempesta B et al. Proposed pathogenesis of Paget-Schroetter disease: impingement of the subclavian vein by a congenitally malformed bony tubercle on the first rib. J Clin Pathol 2012; 65: 262-266 7 Jones MA, Lee DY, Segall JA et al. Characterizing resolution of catheter-associated upper extremity deep venous thrombosis. J Vasc Surg 2010; 51: 108-113 8 Kahn SR, Lim W, Dunn AS et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (Suppl. 02) e195S-226S 9 Kearon C, Akl EA, Comerota AJ et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (Suppl. 02) e419S-e494S 10 Lechner D, Wiener C, Weltermann A et al. Comparison between idiopathic deep vein thrombosis of the upper and lower extremity regarding risk factors and recurrence. J Thromb Haemost 2008; 6: 1269-1274 11 Linnemann B, Meister F, Schwonberg J et al. Hereditary and acquired thrombophilia in patients with upper extremity deep-vein thrombosis. Results from the MAISTHRO registry. Thromb Haemost 2008; 100: 440-446 12 Muñoz FJ, Mismetti P, Poggio R et al. Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry. Chest 2008; 133: 143-148 13 Rathbun SW, Stoner JA, Whitsett TL. Treatment of upper-extremity deep vein thrombosis. J Thromb Haemost 2011; 9: 1924-1930 14 Young AM, Billingham LJ, Begum G et al. Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial. Lancet 2009; 373: 567-574
